Alice Blue Home
URL copied to clipboard

Trending News

Metropolis Healthcare stock up after entering genomics diagnostics space, here’s how

Metropolis Healthcare Limited launched its Centre of Genomics in India to strengthen advanced genomics research, deploy Illumina NovaSeq X Series, and expand access to precision diagnostics nationwide.
Metropolis logo over diagnostic lab with technicians and machines

Introduction

Leading pathology diagnostics chain launched a Centre of Genomics in India to expand advanced genomic testing, research capabilities, and precision medicine across multiple clinical specialties.

Alice Blue Image

Share price movement of Metropolis Healthcare

On January 13, 2026, Metropolis Healthcare Limited opened at ₹1,875.00, marginally higher than its previous close of ₹1,874.95. The stock touched a high of ₹1,881.00 (up 0.32%) and a low of ₹1,851.00. By 10:05 AM, it traded at ₹1,858.20, down 0.89%, with a market capitalisation of ₹9,629.56 crore.

Metropolis Launches Centre of Genomics

Metropolis Healthcare Limited launched its Centre of Genomics in India on January 13, 2026, to scale advanced genomics, molecular diagnostics, precision medicine, and genomic research nationwide.

The Centre integrates two CAP-accredited genomics laboratories in Mumbai and Delhi NCR, supporting oncology, reproductive health, neurology, transplant immunology, and rare disease testing.

Metropolis deployed Illumina’s NovaSeq X Series for research and plans to expand its genomic portfolio to over 500 advanced tests across key clinical specialties.

Stock performance of Metropolis Healthcare for Period of 1 week, 6 months, and 1 year

Metropolis Healthcare Ltd declined 7.62% over the past week, fell 4.42% in six months, and eased 0.41% over the past one year.

Alice Blue Image

Shareholding pattern of Metropolis Healthcare

ParticularsSep 2025Jun 2025Mar 2025
Promoter48.90%48.90%48.90%
FII12.50%12.80%15.30%
DII33.10%32.40%30.30%
Public5.50%5.90%5.50%

About Metropolis Healthcare

Metropolis Healthcare Limited (NSE: METROPOLIS) is India’s second-largest diagnostic chain, offering 4,000+ tests through a nationwide laboratory and service center network since 1981.

Stay Ahead with the Latest Stock Market Updates – Click Here

Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time. The securities quoted are exemplary and are not recommendatory.

FAQs

Q: Why is Metropolis Healthcare Ltd share price rising today?

A: Metropolis Healthcare launches Centre of Genomics in India with CAP-accredited labs, Illumina NovaSeq X Series, and plans for 500 advanced genomic tests.

Q: What is Metropolis Healthcare Ltd’s main business focus?

A: Metropolis Healthcare provides diagnostic services, advanced tests, and actionable health insights across India and Africa through laboratories and service centers.

Q: What is the 52-week high and low of Metropolis Healthcare Ltd stock?

A: Metropolis Healthcare Ltd stock has a 52-week high of ₹2,259.30 and a 52-week low of ₹1,383.70.

Submit the form, and get to know how you scored!!!

Gainers & Losers

Read More News
जैन: 6% अमेरिकी बॉन्ड यील्ड का भारतीय बाजार पर प्रभाव इक्विटी वैल्युएशन में गिरावट का जोखिम पैदा कर सकता है
Trending

जैन: 6% अमेरिकी बॉन्ड यील्ड का भारतीय बाजार पर प्रभाव इक्विटी वैल्युएशन में गिरावट का जोखिम पैदा कर सकता है

भारतीय बाजार पर अमेरिकी बॉन्ड यील्ड का प्रभाव: प्रशांत जैन ने 6% के स्तर पर वैश्विक मंदी और फंड निकासी

*T&C apply